RSAD2 Is an Effective Target for High-Yield Vaccine Production in MDCK Cells

Increasingly, attention has focused on improving vaccine production in cells using gene editing technology to specifically modify key virus regulation-related genes to promote virus replication. In this study, we used DIA proteomics analysis technology to compare protein expression differences betwe...

Full description

Bibliographic Details
Main Authors: Zilin Qiao, Yuejiao Liao, Mengyuan Pei, Zhenyu Qiu, Zhenbin Liu, Dongwu Jin, Jiayou Zhang, Zhongren Ma, Xiaoming Yang
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/11/2587
_version_ 1797463801287671808
author Zilin Qiao
Yuejiao Liao
Mengyuan Pei
Zhenyu Qiu
Zhenbin Liu
Dongwu Jin
Jiayou Zhang
Zhongren Ma
Xiaoming Yang
author_facet Zilin Qiao
Yuejiao Liao
Mengyuan Pei
Zhenyu Qiu
Zhenbin Liu
Dongwu Jin
Jiayou Zhang
Zhongren Ma
Xiaoming Yang
author_sort Zilin Qiao
collection DOAJ
description Increasingly, attention has focused on improving vaccine production in cells using gene editing technology to specifically modify key virus regulation-related genes to promote virus replication. In this study, we used DIA proteomics analysis technology to compare protein expression differences between two groups of MDCK cells: uninfected and influenza A virus (IAV) H1N1-infected cells 16 h post infection (MOI = 0.01). Initially, 266 differentially expressed proteins were detected after infection, 157 of which were upregulated and 109 were downregulated. We screened these proteins to 23 genes related to antiviral innate immunity regulation based on functional annotation database analysis and verified the mRNA expression of these genes using qPCR. Combining our results with published literature, we focused on the proteins RSAD2, KCNN4, IDO1, and ISG20; we verified their expression using western blot, which was consistent with our proteomics results. Finally, we knocked down RSAD2 using lentiviral shRNA expression vectors and found that RSAD2 inhibition significantly increased IAV NP gene expression, effectively promoting influenza virus replication with no significant effect on cell proliferation. These results indicate that RSAD2 is potentially an effective target for establishing high-yield vaccine MDCK cell lines and will help to fully understand the interaction mechanism between host cells and influenza viruses.
first_indexed 2024-03-09T17:55:53Z
format Article
id doaj.art-1702d9ce028e48ec95ca4d603b2b1b03
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-09T17:55:53Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-1702d9ce028e48ec95ca4d603b2b1b032023-11-24T10:19:39ZengMDPI AGViruses1999-49152022-11-011411258710.3390/v14112587RSAD2 Is an Effective Target for High-Yield Vaccine Production in MDCK CellsZilin Qiao0Yuejiao Liao1Mengyuan Pei2Zhenyu Qiu3Zhenbin Liu4Dongwu Jin5Jiayou Zhang6Zhongren Ma7Xiaoming Yang8Gansu Tech Innovation Center of Animal Cell, Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, ChinaGansu Tech Innovation Center of Animal Cell, Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, ChinaGansu Tech Innovation Center of Animal Cell, Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, ChinaGansu Tech Innovation Center of Animal Cell, Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, ChinaGansu Tech Innovation Center of Animal Cell, Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, ChinaGansu Provincial Bioengineering Materials Engineering Research Center, Lanzhou Minhai Bio-Engineering Co., Ltd., Lanzhou 730030, ChinaNational Engineering Technology Research Center for Combined Vaccines, Wuhan 430207, ChinaGansu Tech Innovation Center of Animal Cell, Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, ChinaNational Engineering Technology Research Center for Combined Vaccines, Wuhan 430207, ChinaIncreasingly, attention has focused on improving vaccine production in cells using gene editing technology to specifically modify key virus regulation-related genes to promote virus replication. In this study, we used DIA proteomics analysis technology to compare protein expression differences between two groups of MDCK cells: uninfected and influenza A virus (IAV) H1N1-infected cells 16 h post infection (MOI = 0.01). Initially, 266 differentially expressed proteins were detected after infection, 157 of which were upregulated and 109 were downregulated. We screened these proteins to 23 genes related to antiviral innate immunity regulation based on functional annotation database analysis and verified the mRNA expression of these genes using qPCR. Combining our results with published literature, we focused on the proteins RSAD2, KCNN4, IDO1, and ISG20; we verified their expression using western blot, which was consistent with our proteomics results. Finally, we knocked down RSAD2 using lentiviral shRNA expression vectors and found that RSAD2 inhibition significantly increased IAV NP gene expression, effectively promoting influenza virus replication with no significant effect on cell proliferation. These results indicate that RSAD2 is potentially an effective target for establishing high-yield vaccine MDCK cell lines and will help to fully understand the interaction mechanism between host cells and influenza viruses.https://www.mdpi.com/1999-4915/14/11/2587DIAMDCKinfluenza virusRSAD2vaccine
spellingShingle Zilin Qiao
Yuejiao Liao
Mengyuan Pei
Zhenyu Qiu
Zhenbin Liu
Dongwu Jin
Jiayou Zhang
Zhongren Ma
Xiaoming Yang
RSAD2 Is an Effective Target for High-Yield Vaccine Production in MDCK Cells
Viruses
DIA
MDCK
influenza virus
RSAD2
vaccine
title RSAD2 Is an Effective Target for High-Yield Vaccine Production in MDCK Cells
title_full RSAD2 Is an Effective Target for High-Yield Vaccine Production in MDCK Cells
title_fullStr RSAD2 Is an Effective Target for High-Yield Vaccine Production in MDCK Cells
title_full_unstemmed RSAD2 Is an Effective Target for High-Yield Vaccine Production in MDCK Cells
title_short RSAD2 Is an Effective Target for High-Yield Vaccine Production in MDCK Cells
title_sort rsad2 is an effective target for high yield vaccine production in mdck cells
topic DIA
MDCK
influenza virus
RSAD2
vaccine
url https://www.mdpi.com/1999-4915/14/11/2587
work_keys_str_mv AT zilinqiao rsad2isaneffectivetargetforhighyieldvaccineproductioninmdckcells
AT yuejiaoliao rsad2isaneffectivetargetforhighyieldvaccineproductioninmdckcells
AT mengyuanpei rsad2isaneffectivetargetforhighyieldvaccineproductioninmdckcells
AT zhenyuqiu rsad2isaneffectivetargetforhighyieldvaccineproductioninmdckcells
AT zhenbinliu rsad2isaneffectivetargetforhighyieldvaccineproductioninmdckcells
AT dongwujin rsad2isaneffectivetargetforhighyieldvaccineproductioninmdckcells
AT jiayouzhang rsad2isaneffectivetargetforhighyieldvaccineproductioninmdckcells
AT zhongrenma rsad2isaneffectivetargetforhighyieldvaccineproductioninmdckcells
AT xiaomingyang rsad2isaneffectivetargetforhighyieldvaccineproductioninmdckcells